# Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

> **NCT00736645** · PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 55 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** selenomethionine
- **DRUG:** finasteride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00736645
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736645, "Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00736645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*